Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Jul 26, 2026
Rocket Lab (RKLB) Needs a +56% Rally to Reach $100 – What Stands in the Way

Rocket Lab (RKLB) Needs a +56% Rally to Reach $100 – What Stands in the Way

Key Takeaways

  • Rocket Lab shares closed at $63.91 on July 24, 2026, meaning the stock would need to climb approximately 56% to reclaim the psychologically significant $100 level.
  • The strongest bullish catalyst is Neutron, the company's medium-lift reusable rocket targeting a debut launch in the fourth quarter of 2026, which could unlock a $5.6 billion national security launch program and dramatically expand the revenue base.
  • Rocket Lab's record $2.2 billion backlog and 63.5% year-over-year revenue growth in Q1 2026 demonstrate strong operational momentum, while the pending $8 billion Iridium acquisition could transform the company into a vertically integrated space platform with recurring services revenue.
  • Valuation and dilution risks remain significant obstacles. The stock trades at roughly 66 times trailing sales, insider selling has weighed on sentiment, and a $3 billion at-the-market equity offering has raised concerns about shareholder dilution.
  • Wall Street consensus suggests $100 is achievable. The average analyst price target stands near $110, with most targets clustering between $96 and $135, though the Street-low target of $60 underscores the wide range of possible outcomes.

Why Investors Are Watching the $100 Level

After peaking near $151 in May 2026, Rocket Lab Corporation (NASDAQ: RKLB) has endured a punishing drawdown of more than 55%, wiping out the year's gains and sending shares tumbling into the mid-$60s. The speed and severity of the sell-off — driven by a broader post-SpaceX IPO rotation out of space stocks, a dilutive equity offering, and a securities class action — has left investors asking whether the stock can mount a meaningful recovery. The $100 round-number level has emerged as the most visible near-term milestone: it sits just below the analyst consensus, represents the threshold that separated the stock's rally phase from its correction, and carries the psychological weight that round numbers command in technical analysis.

Company Overview

Rocket Lab is an end-to-end space company headquartered in Long Beach, California, founded in 2006 by CEO Sir Peter Beck. Unlike pure-play launch providers, Rocket Lab operates across two segments: Launch Services, anchored by the frequently flown Electron small orbital rocket, and Space Systems, which designs and manufactures satellites, spacecraft components, and on-orbit infrastructure. The company has delivered more than 1,700 satellites to orbit, operates three launch pads across New Zealand and Virginia, and is developing Neutron, a medium-lift reusable rocket designed to compete directly with SpaceX's Falcon 9 in the constellation-deployment and national security markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

What Could Drive the Stock Back to $100

The single most important variable for the Rocket Lab thesis is Neutron's debut flight, now targeted for the fourth quarter of 2026. A successful first launch would make Rocket Lab eligible to compete for individual task orders under the Space Force's National Security Space Launch (NSSL) Phase 3 Lane 1 program, a contract vehicle carrying a $5.6 billion ceiling through 2029. The Archimedes engine that powers Neutron recently completed a full-duration qualification burn at NASA's Stennis Space Center — a milestone that keeps the timeline credible despite an earlier tank-test failure that pushed the schedule from mid-2026 into the fourth quarter.

Beyond Neutron, the fundamental momentum is difficult to dismiss. First-quarter fiscal 2026 revenue reached $200.35 million, up 63.5% year over year, while the contracted backlog swelled to a record $2.2 billion. Rocket Lab also secured an $816 million Space Development Agency contract for 18 tracking-layer satellites and was selected alongside Raytheon for the Golden Dome Space-Based Interceptor program — placing the company at the center of the highest-priority U.S. defense space budgets.

The pending $8 billion acquisition of Iridium Communications, announced in late June 2026, represents a transformative bet. If the deal closes as expected in mid-2027, Rocket Lab would add a global satellite communications network, L-band spectrum, and more than 2.5 million recurring subscribers — evolving from a launch provider into a vertically integrated space platform that more closely resembles the SpaceX model Morgan Stanley has cited in its analysis.

Analyst Consensus: Cautious Optimism

The broader analyst community remains constructive despite the sell-off. Across 22 analysts, the consensus rating is Moderate Buy, with an average price target of approximately $110, implying roughly 72% upside from the most recent close. High-profile targets include Needham at $120, Keybanc at $135, and Bank of America at $115. Morgan Stanley maintains an Overweight rating with a $105 base case while simultaneously raising its bull-case scenario to $293, reflecting the optionality tied to Neutron, Iridium, and Golden Dome contract conversions. On the more cautious side, Piper Sandler initiated coverage in mid-July with a Neutral rating and an $83 target, arguing the stock remains expensive even after falling more than 50% from its peak. The range of opinion — from $60 at Wells Fargo to $150 at the high end — underscores how much depends on execution over the next two quarters.

Risks That Could Prevent the Move

Rocket Lab remains an unprofitable company. Fiscal 2025 revenue of $601.8 million was accompanied by a net loss of $198 million, and the company trades at roughly 66 times trailing sales — a multiple that prices in years of flawless execution. Any Neutron delay beyond late 2026, whether from technical setbacks or certification hurdles, would delay the medium-lift revenue stream that the valuation thesis depends on and could trigger further equity dilution.

Additional headwinds include a $3 billion at-the-market equity offering announced in June, which raised dilution concerns, and insider selling from CEO Peter Beck, who disclosed the sale of nearly 3 million shares in early July. A securities class action filed over Neutron timeline disclosures has added legal uncertainty to the mix. Meanwhile, the post-SpaceX IPO rotation has not yet run its course, and with a beta of approximately 2.55, RKLB amplifies every shift in market sentiment — in both directions.

Technical Levels That Matter

From a technical perspective, $100 also aligns as the approximate midpoint between the 52-week high of $151 and key support near $60 — the Street-low analyst target and a level the stock tested during the recent sell-off. The 200-day simple moving average, sitting around $76, represents a nearer-term hurdle; the stock would need to reclaim that level before any sustained move toward triple digits gains credibility. The $80 to $85 zone, where the stock consolidated during portions of June and early July, may also act as an intermediate resistance area. I reviewed the recent patterns using Tickeron’s AI Pattern Search Engine to confirm the key levels.

Using AI Tools to Navigate Volatile Names

One tool I’ve found helpful for navigating stocks like this is Tickeron’s AI Daily Buy/Sell Signals. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. Rather than manually scanning charts and news feeds, I can use these signals to identify emerging opportunities, monitor existing positions, and spot shifts in market trends more efficiently. For investors tracking whether RKLB can sustain a recovery toward $100, automated signal monitoring can help filter the noise from the signal.

Final Assessment

Can Rocket Lab reach $100? The arithmetic says yes — a 56% rally from $63.91 is well within this stock's normal range of motion, and it has already traded well above $100 earlier in 2026. The question is less about capability and more about timing and conditions. A clean Neutron debut in the fourth quarter, continued backlog conversion at or above current growth rates, and tangible progress on the Iridium integration would likely provide the fundamental fuel to drive shares back through $100. Conversely, a Neutron delay into 2027, further dilution, or deteriorating sentiment across the space sector would make that target considerably more difficult. For now, $100 remains a reachable but non-trivial milestone — one that demands execution, not merely ambition. The upcoming Q2 earnings report on August 6 may offer the next meaningful signal about which direction the stock is poised to take.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RKLB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RKLB's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for RKLB turned positive on July 31, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where RKLB's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RKLB broke above its upper Bollinger Band on August 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RKLB entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (13.280) is normal, around the industry mean (7.037). P/E Ratio (0.000) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (55.249) is also within normal values, averaging (20.174).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
RKLB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry AerospaceDefense

Profile
Details
Industry
N/A
Address
3881 McGowen Street
Phone
+1 714 465-5737
Employees
2600
Web
https://www.rocketlabusa.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.